| Dr Paul Fortaleza, DO | |
|
6350 Laurel Canyon Blvd Ste 205, North Hollywood, CA 91606-3278 | |
| (818) 325-2090 | |
| Not Available |
| Full Name | Dr Paul Fortaleza |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 30 Years |
| Location | 6350 Laurel Canyon Blvd Ste 205, North Hollywood, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336368190 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mma Home Health Care, Inc | Glendale, CA | Home health agency |
| Barstow Community Hospital | Barstow, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Osher Resources Inc | 3072832609 | 2 |
News Archive
More than one in four Americans has taken prescription painkillers in the past year, even as a majority say that abuse of these medications is a very serious public health concern, according to new Johns Hopkins Bloomberg School of Public Health research.
Loyola University Medical Center stroke specialist Jose Biller, MD is among four Hispanic leaders being recognized by the American Heart Association/American Stroke Association for their contributions to improving the health and well-being of multicultural communities.
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
Researchers in the Hereditary Endocrine Cancer Group of the Spanish National Cancer Research Centre - led by Alberto Cascón and Mercedes Robledo - have described the presence of mutations in the MDH2 gene, in a family with very rare neuroendocrine tumours associated with a high hereditary component: pheochromocytomas and paragangliomas that affect the suprarenal and parathyroid glands (groups of chromaffin cells in the central nervous system), respectively.
› Verified 8 days ago
| Entity Name | County Of Los Angeles |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851363188 PECOS PAC ID: 1850296534 Enrollment ID: O20031204001218 |
News Archive
More than one in four Americans has taken prescription painkillers in the past year, even as a majority say that abuse of these medications is a very serious public health concern, according to new Johns Hopkins Bloomberg School of Public Health research.
Loyola University Medical Center stroke specialist Jose Biller, MD is among four Hispanic leaders being recognized by the American Heart Association/American Stroke Association for their contributions to improving the health and well-being of multicultural communities.
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
Researchers in the Hereditary Endocrine Cancer Group of the Spanish National Cancer Research Centre - led by Alberto Cascón and Mercedes Robledo - have described the presence of mutations in the MDH2 gene, in a family with very rare neuroendocrine tumours associated with a high hereditary component: pheochromocytomas and paragangliomas that affect the suprarenal and parathyroid glands (groups of chromaffin cells in the central nervous system), respectively.
› Verified 8 days ago
| Entity Name | Veterans Home Of California Barstow |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205821758 PECOS PAC ID: 5294707642 Enrollment ID: O20040806001182 |
News Archive
More than one in four Americans has taken prescription painkillers in the past year, even as a majority say that abuse of these medications is a very serious public health concern, according to new Johns Hopkins Bloomberg School of Public Health research.
Loyola University Medical Center stroke specialist Jose Biller, MD is among four Hispanic leaders being recognized by the American Heart Association/American Stroke Association for their contributions to improving the health and well-being of multicultural communities.
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
Researchers in the Hereditary Endocrine Cancer Group of the Spanish National Cancer Research Centre - led by Alberto Cascón and Mercedes Robledo - have described the presence of mutations in the MDH2 gene, in a family with very rare neuroendocrine tumours associated with a high hereditary component: pheochromocytomas and paragangliomas that affect the suprarenal and parathyroid glands (groups of chromaffin cells in the central nervous system), respectively.
› Verified 8 days ago
| Entity Name | Osher Resources Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700282654 PECOS PAC ID: 3072832609 Enrollment ID: O20150504001942 |
News Archive
More than one in four Americans has taken prescription painkillers in the past year, even as a majority say that abuse of these medications is a very serious public health concern, according to new Johns Hopkins Bloomberg School of Public Health research.
Loyola University Medical Center stroke specialist Jose Biller, MD is among four Hispanic leaders being recognized by the American Heart Association/American Stroke Association for their contributions to improving the health and well-being of multicultural communities.
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
Researchers in the Hereditary Endocrine Cancer Group of the Spanish National Cancer Research Centre - led by Alberto Cascón and Mercedes Robledo - have described the presence of mutations in the MDH2 gene, in a family with very rare neuroendocrine tumours associated with a high hereditary component: pheochromocytomas and paragangliomas that affect the suprarenal and parathyroid glands (groups of chromaffin cells in the central nervous system), respectively.
› Verified 8 days ago
| Entity Name | Department Of Veterans Affairs Of The State Of California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396165353 PECOS PAC ID: 6507099520 Enrollment ID: O20150818004043 |
News Archive
More than one in four Americans has taken prescription painkillers in the past year, even as a majority say that abuse of these medications is a very serious public health concern, according to new Johns Hopkins Bloomberg School of Public Health research.
Loyola University Medical Center stroke specialist Jose Biller, MD is among four Hispanic leaders being recognized by the American Heart Association/American Stroke Association for their contributions to improving the health and well-being of multicultural communities.
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
Researchers in the Hereditary Endocrine Cancer Group of the Spanish National Cancer Research Centre - led by Alberto Cascón and Mercedes Robledo - have described the presence of mutations in the MDH2 gene, in a family with very rare neuroendocrine tumours associated with a high hereditary component: pheochromocytomas and paragangliomas that affect the suprarenal and parathyroid glands (groups of chromaffin cells in the central nervous system), respectively.
› Verified 8 days ago
| Entity Name | B & D Hospice Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225321631 PECOS PAC ID: 1850569039 Enrollment ID: O20200317000631 |
News Archive
More than one in four Americans has taken prescription painkillers in the past year, even as a majority say that abuse of these medications is a very serious public health concern, according to new Johns Hopkins Bloomberg School of Public Health research.
Loyola University Medical Center stroke specialist Jose Biller, MD is among four Hispanic leaders being recognized by the American Heart Association/American Stroke Association for their contributions to improving the health and well-being of multicultural communities.
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
Researchers in the Hereditary Endocrine Cancer Group of the Spanish National Cancer Research Centre - led by Alberto Cascón and Mercedes Robledo - have described the presence of mutations in the MDH2 gene, in a family with very rare neuroendocrine tumours associated with a high hereditary component: pheochromocytomas and paragangliomas that affect the suprarenal and parathyroid glands (groups of chromaffin cells in the central nervous system), respectively.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Paul Fortaleza, DO 6350 Laurel Canyon Blvd Ste 205, North Hollywood, CA 91606-3278 Ph: (818) 325-2090 | Dr Paul Fortaleza, DO 6350 Laurel Canyon Blvd Ste 205, North Hollywood, CA 91606-3278 Ph: (818) 325-2090 |
News Archive
More than one in four Americans has taken prescription painkillers in the past year, even as a majority say that abuse of these medications is a very serious public health concern, according to new Johns Hopkins Bloomberg School of Public Health research.
Loyola University Medical Center stroke specialist Jose Biller, MD is among four Hispanic leaders being recognized by the American Heart Association/American Stroke Association for their contributions to improving the health and well-being of multicultural communities.
Sanofi-aventis reported today new one-year data from a Phase II study with teriflunomide, a novel oral disease modifier being investigated for the treatment of relapsing multiple sclerosis (RMS). Study results demonstrated an improvement in outcomes, with a consistent safety profile with the data from a previous Phase II monotherapy study, in patients treated with interferon beta (IFN-[BETA]) - a standard therapy in RMS - and receiving teriflunomide 7mg or 14mg, compared with patients treated with IFN-[BETA] and receiving oral placebo.
Researchers in the Hereditary Endocrine Cancer Group of the Spanish National Cancer Research Centre - led by Alberto Cascón and Mercedes Robledo - have described the presence of mutations in the MDH2 gene, in a family with very rare neuroendocrine tumours associated with a high hereditary component: pheochromocytomas and paragangliomas that affect the suprarenal and parathyroid glands (groups of chromaffin cells in the central nervous system), respectively.
› Verified 8 days ago
Mr. Rizalino G Vicente, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7544 Laurel Canyon Blvd, North Hollywood, CA 91605 Phone: 818-691-3260 Fax: 818-691-3293 | |
Dr. Wanjiku Ann Maxine Moite, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 7843 Lankershim Blvd, North Hollywood, CA 91605 Phone: 818-765-8656 Fax: 818-765-6982 | |
Nesyah Shaesteh, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11631 Victory Blvd, North Hollywood, CA 91606 Phone: 818-764-8838 | |
Armine Manukyan, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6350 Laurel Canyon Blvd Ste 205, North Hollywood, CA 91606 Phone: 818-653-3959 | |
Mr. Daniel M. Rose, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 12134 Victory Blvd, North Hollywood, CA 91606 Phone: 818-762-8702 Fax: 818-761-2583 | |
Lisa Michelle Blum Zeelander, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 6801 Coldwater Canyon Ave, North Hollywood, CA 91605 Phone: 818-301-6331 Fax: 818-766-8352 | |
Vahe Ter-yegishyan, FNP-C Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 10651 Riverside Dr, North Hollywood, CA 91602 Phone: 818-747-2470 |